mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.003 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |